Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
$5.23
+0.8%		$5.97
$5.00
▼
$8.74
$72.63M0.48,109 shs245 shs
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$6.39
+3.3%		$6.14
$3.75
▼
$9.40
$28.84M1.4938,440 shs4,396 shs
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
$1.30
+1.2%		$1.52
$0.99
▼
$3.25
$60.49M0.84398,129 shs7,096 shs
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
$1.67
-19.6%		$1.90
$1.66
▼
$4.94
$77.80M1.44221,487 shs766,757 shs
7 Stocks to Buy And Hold Forever Cover
7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
-2.08%-1.33%-13.64%-13.79%-19.72%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-2.83%+1.64%-6.64%-10.16%+22.57%
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
-3.03%-6.71%-15.23%+0.79%+127,999,900.00%
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-1.42%-1.42%+19.54%-20.91%-39.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
$5.23
+0.8%		$5.97
$5.00
▼
$8.74
$72.63M0.48,109 shs245 shs
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$6.39
+3.3%		$6.14
$3.75
▼
$9.40
$28.84M1.4938,440 shs4,396 shs
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
$1.30
+1.2%		$1.52
$0.99
▼
$3.25
$60.49M0.84398,129 shs7,096 shs
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
$1.67
-19.6%		$1.90
$1.66
▼
$4.94
$77.80M1.44221,487 shs766,757 shs
7 Stocks to Buy And Hold Forever Cover
7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
-2.08%-1.33%-13.64%-13.79%-19.72%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-2.83%+1.64%-6.64%-10.16%+22.57%
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
-3.03%-6.71%-15.23%+0.79%+127,999,900.00%
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-1.42%-1.42%+19.54%-20.91%-39.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
1.00
SellN/AN/A
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
2.00
Hold$6.00-6.16% Downside
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
2.40
Hold$5.00286.10% Upside
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
2.33
Hold$6.00258.85% Upside

Current Analyst Ratings Breakdown

Latest HBIO, RPID, CSBR, and HYFT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/28/2026
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
7/20/2026
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
7/17/2026
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/15/2026
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/30/2026
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
6/24/2026
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
6/15/2026
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
5/29/2026
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
KeyCorp logo
KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$8.00 ➝ $5.00
5/22/2026
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
5/22/2026
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$8.00 ➝ $7.00
5/19/2026
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$5.00
(Data available from 8/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
$59.42M1.22$0.01 per share364.36$0.29 per share18.03
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$85.53M0.34$11.84 per share0.54$3.07 per share2.08
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
$11.24M5.38N/AN/A$0.18 per share7.19
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
$33.59M2.30N/AN/A$0.75 per share2.23
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
-$1.17M-$0.08N/AN/AN/A-1.87%-27.48%-3.84%9/14/2026 (Estimated)
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-$56.70M-$2.17N/AN/AN/A-11.44%-25.78%-4.37%8/11/2026 (Estimated)
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
-$10.11M-$0.22N/AN/AN/A-89.65%-92.61%-54.15%N/A
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-$47.12M-$1.12N/AN/AN/A-145.81%-131.52%-67.48%8/7/2026 (Estimated)

Latest HBIO, RPID, CSBR, and HYFT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-$0.21N/AN/AN/A$21.45 millionN/A
8/7/2026Q2 2026
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-$0.2433-$0.27-$0.0267-$0.27$7.88 million$8.05 million
7/27/2026Q4 2026
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
-$0.05$0.01+$0.06-$0.05$12.89 million$13.84 million
7/22/2026Q4 2026
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
-$0.05-$0.06-$0.01-$0.06N/A$3.03 million
5/13/2026Q1 2026
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
-$0.25-$0.31-$0.06-$0.31$7.60 million$8.00 million
5/12/2026Q1 2026
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-$0.62-$0.33+$0.29-$0.77$21.20 million$20.76 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
N/AN/AN/AN/AN/A
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
N/AN/AN/AN/AN/A
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
N/AN/AN/AN/AN/A
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
N/A
0.96
0.96
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
3.60
1.99
1.06
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
0.26
2.80
2.72
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
0.93
2.57
1.66

Institutional Ownership

CompanyInstitutional Ownership
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
41.30%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
80.87%
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
6.70%
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
52.60%

Insider Ownership

CompanyInsider Ownership
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
46.98%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
17.03%
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
6.83%
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
12.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Champions Oncology, Inc. stock logo
CSBR
Champions Oncology
14313.89 million7.37 millionOptionable
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
4904.51 million3.74 millionOptionable
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
8046.71 million43.52 millionN/A
Rapid Micro Biosystems, Inc. stock logo
RPID
Rapid Micro Biosystems
20046.17 million40.31 millionNot Optionable

Recent News About These Companies

Rapid Micro Biosystems Q2 Earnings Call Highlights
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/rapid-micro-biosystems-q2-earnings-call-highlights-2026-08-07/
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates
 |  zacks.comhttps://www.zacks.com/stock/news/2970787/rapid-micro-biosystems-inc-rpid-reports-q2-loss-tops-revenue-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_4-2970787
Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results
 |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/07/3341032/33206/en/rapid-micro-biosystems-reports-second-quarter-2026-financial-results.html
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 4 at 4:30 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/04/3338867/33206/en/rapid-micro-biosystems-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html
Rapid Micro Biosystems (RPID) Projected to Post Quarterly Earnings on Friday
July 31, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30931593
Rapid Micro Biosystems (RPID) Projected to Release Quarterly Earnings on Friday
July 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/rapid-micro-biosystems-rpid-projected-to-release-quarterly-earnings-on-friday-2026-07-31/
Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026
July 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/23/3332637/33206/en/rapid-micro-biosystems-to-announce-second-quarter-2026-financial-results-on-august-7-2026.html
Rapid Micro Biosystems (RPID)
June 24, 2026  |  zacks.comhttps://www.zacks.com/stock/chart/RPID/broker-recommendations
Rapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 10, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/rapid-micro-biosystems-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4-1036240610
Rapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 10, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/10/3310119/33206/en/rapid-micro-biosystems-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4.html
Rapid Micro Biosystems prices $9.8M capital raise with up to $21.7M in additional warrant potential
May 19, 2026  |  msn.comhttps://www.msn.com/en-us/money/companies/rapid-micro-biosystems-prices-9-8m-capital-raise-with-up-to-21-7m-in-additional-warrant-potential/ar-AA23xohy
Rapid Micro Biosystems Announces Pricing of $9.8 Million Underwritten Public Offering of Class A Common Stock and Warrants
May 18, 2026  |  quiverquant.comQ
Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering
May 18, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/19/3297111/33206/en/rapid-micro-biosystems-announces-pricing-of-up-to-approximately-32-million-underwritten-offering.html
Rapid Micro Biosystems Earnings Call Balances Growth And Risk
May 16, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/RPID/pressreleases/1968086/rapid-micro-biosystems-earnings-call-balances-growth-and-risk/
Rapid Micro Biosystems Q1 2026 Earnings Call: Complete Transcript
May 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/rapid-micro-biosystems-q1-2026-213143024.html
Rapid Micro Biosystems Inc (RPID) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ...
May 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/rapid-micro-biosystems-inc-rpid-050204433.html
Rapid Micro Biosystems, Inc. (RPID) Q1 2026 Earnings Call Transcript
May 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4904314-rapid-micro-biosystems-inc-rpid-q1-2026-earnings-call-transcript
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
May 13, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2920899/rapid-micro-biosystems-inc-rpid-reports-q1-loss-tops-revenue-estimates?cid=cs-stocknewsapi-ft-tale_of_the_tape|yseop_template_4-2920899
Rapid Micro Biosystems Reports First Quarter 2026 Revenue of $8.0 Million with 11% Year-Over-Year Growth
May 13, 2026  |  quiverquant.comQ
Rapid Micro Biosystems Reports First Quarter 2026 Financial Results
May 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/13/3294462/33206/en/rapid-micro-biosystems-reports-first-quarter-2026-financial-results.html
Rapid Micro Biosystems to Announce First Quarter 2026 Financial Results on May 13, 2026
May 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/06/3289376/33206/en/rapid-micro-biosystems-to-announce-first-quarter-2026-financial-results-on-may-13-2026.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Champions Oncology stock logo

Champions Oncology NASDAQ:CSBR

$5.23 +0.04 (+0.75%)
As of 11:14 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. It uses its technology to offer solutions to Translational Oncology Solutions, which includes pharmaceutical and biotechnology companies; and Personalized Oncology, which assists physicians in developing personalized treatment options for their cancer patients. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.

Harvard Bioscience stock logo

Harvard Bioscience NASDAQ:HBIO

$6.39 +0.20 (+3.30%)
As of 11:18 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

MindWalk stock logo

MindWalk NASDAQ:HYFT

$1.30 +0.02 (+1.17%)
As of 11:22 AM Eastern
This is a fair market value price provided by Massive. Learn more.

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.

Rapid Micro Biosystems stock logo

Rapid Micro Biosystems NASDAQ:RPID

$1.67 -0.41 (-19.62%)
As of 11:25 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas